U.S. Venture Partners

Four generations of knowledge and three decades of investing in innovation

Sinus implant maker Intersect ENT files for an $80 million IPO

Intersect ENT, which sells drug-eluting implants that maintain relief from chronic sinusitis after surgery, filed on Monday with the SEC to raise up to $80 million in an initial public offering.Read More

Hotshot! GoPro up 30% in stock debut

Hotshot! GoPro up 30% in stock debutRead More